Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18 | 91 | 30 | 128 | 204 |
| Receivables | 22 | 22 | 27 | 11 | 6 |
| TOTAL | $52 | $113 | $61 | $138 | $210 |
| Non-Current Assets | |||||
| PPE Net | 317 | 298 | 302 | 324 | 360 |
| Investments And Advances | 56 | 0 | 0 | 0 | 0 |
| TOTAL | $373 | $298 | $302 | $324 | $360 |
| Total Assets | $425 | $412 | $363 | $463 | $570 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 57 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 189 | 362 | 199 | 114 | 442 |
| TOTAL | $253 | $369 | $206 | $121 | $442 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 252 | 197 | 201 | 96 | 51 |
| TOTAL | $252 | $197 | $201 | $96 | $51 |
| Total Liabilities | $505 | $566 | $407 | $217 | $493 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 21,760 | 16,114 | 13,114 | 11,864 | 9,264 |
| Common Shares | 2 | 2 | 1 | 1 | 1 |
| Retained earnings | -3,141 | -2,674 | -2,492 | -2,112 | -1,675 |
| Other shareholders' equity | 21 | 0 | 0 | 0 | 0 |
| TOTAL | $-80 | $-154 | $-44 | $245 | $78 |
| Total Liabilities And Equity | $425 | $412 | $363 | $463 | $570 |